MELISSA KISTNER: Open Payments
NPI 1679051106 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 29 payments from 16 companies in 2025. Trend: 2023 $532 · 2024 $489 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| Pharming Healthcare, Inc. | 2 | $146 |
| GENZYME CORPORATION | 4 | $132 |
| CSL Behring | 5 | $92 |
| Regeneron Healthcare Solutions, Inc. | 4 | $81 |
| BioCryst US Sales Co., LLC | 1 | $35 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Genentech USA, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $23 |
Products named: DUPIXENT, RUCONEST, Andembry, ORLADEYO, INSPIRE, NUCALA, Xolair, ZEPBOUND.
Industry payments across VA — which companies pay providers there.
